dronedarone has been researched along with Anesthesia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatelain, P; Heyndrickx, JP; Hodeige, D; Manning, A | 1 |
| Leunissen, HD; van Opstal, JM; Verduyn, SC; Vos, MA; Wellens, HJ | 1 |
| de Groot, SH; Leunissen, JD; Molenschot, MM; Schoenmakers, M; van Der Hulst, FF; van Opstal, JM; Verduyn, SC; Vos, MA; Wellens, HJ | 1 |
3 other study(ies) available for dronedarone and Anesthesia
| Article | Year |
|---|---|
SR 33589, a new amiodarone-like antiarrhythmic agent: anti-adrenoceptor activity in anaesthetized and conscious dogs.
Topics: Administration, Oral; Adrenergic Antagonists; Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Benzofurans; Blood Pressure; Dogs; Dronedarone; Electrocardiography; Female; Heart Rate; Injections, Intravenous; Isoproterenol; Male | 1995 |
Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias.
Topics: Action Potentials; Administration, Oral; Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Dogs; Dronedarone; Electrocardiography; Female; Heart Ventricles; Injections, Intravenous; Male; Propanolamines; Time Factors; Torsades de Pointes; Ventricular Function | 1999 |
Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
Topics: Action Potentials; Administration, Oral; Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Catheterization; Disease Models, Animal; Dogs; Dronedarone; Electrocardiography; Electrophysiologic Techniques, Cardiac; Epinephrine; Female; Heart Block; Hemodynamics; Long QT Syndrome; Male; Myocardium; Organ Size; Torsades de Pointes; Vasoconstrictor Agents; Wakefulness | 2001 |